Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TYK-01054 in Advanced Solid Tumors (Phase I/II)
CTR20255003Phase 2Active
- Sponsor
- TYK Medicines
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TY-1054 in Nonhematologic neoplasms, mesothelioma, epithelioid hemangioendothelioma (EHE), head and neck squamous cell carcinoma (HNSCC), colorectal cancer (CRC), sponsored by TYK Medicines. Started Dec 2025; status: active.
02
Drugs
TY-1054
03
Conditions
Nonhematologic neoplasmsmesotheliomaepithelioid hemangioendothelioma (EHE)head and neck squamous cell carcinoma (HNSCC)colorectal cancer (CRC)
Beyond the preview
Go deeper on CTR20255003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255003.